Monoclonal antibody therapy of herpes simplex virus: an opportunity to decrease congenital and perinatal infections

HIGHLIGHTS

• who: Iara M. Backes from the The University of Melbourne, Australia have published the research: Monoclonal antibody therapy of herpes simplex virus: An opportunity to decrease congenital and perinatal infections, in the Journal: (JOURNAL)

SUMMARY

The World Health Organization estimates that around the world over 3.7 billion people have oral herpes infections, and that approximately half a billion people experience genital herpes. Herpes simplex virus (HSV) infects the host for their lifetime by infecting neurons of the peripheral nervous system or central nervous system (CNS), the virus can then reactivate asymptomatically or . . .

 



If you want to have access to all the content you need to log in!

Thanks :)

Username or Email

Password

Remember me

Lost your password?

If you don't have an account, you can create one here.